Temple University Biotech Spinout Acquired for $53M

By BioBuzz Networks · Published December 2, 2024 · 1 min read · Greater Philadelphia

Renovacor was spun out of Temple with the goal of developing drugs to combat genetic cardiological diseases.

Read the full article at: www.bizjournals.com

Tagged:

BioBuzz is a life science media and community organization connecting professionals, companies, and organizations across the Mid-Atlantic region.

Upcoming Events